In recent years the U.S. has seen a dramatic resurgence of research into the medical use of psychedelics, after the drug war put a decades-long halt on scientific advancement. Despite psilocybin, LSD and other hallucinogens still being labeled as "Schedule 1" drugs, researchers are discovering the astounding benefits of their medical application.
Last December, pioneering clinical trials found that magic mushrooms heal mental illness like a "surgical intervention." Advanced cancer patients have "experienced immediate and dramatic reductions in anxiety and depression, improvements that were sustained for at least six months." Psychedelics can treat addiction, ADHD and PTSD, and can replace years of depression therapy. Alongside medical cannabis, psychedelics can arguably solve the opioid epidemic.